Estrella Immunopharma Stock Forward View - Simple Moving Average
| ESLA Stock | 1.12 0.04 3.70% |
Estrella Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Estrella Immunopharma stock prices and determine the direction of Estrella Immunopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Estrella Immunopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Estrella Immunopharma's share price is approaching 41 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Estrella Immunopharma, making its price go up or down. Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Next Year (0.72) | Wall Street Target Price 16 | EPS Estimate Current Quarter (0.11) |
Using Estrella Immunopharma hype-based prediction, you can estimate the value of Estrella Immunopharma from the perspective of Estrella Immunopharma response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Estrella Immunopharma on the next trading day is expected to be 1.12 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 7.77. Estrella Immunopharma after-hype prediction price | USD 1.12 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Estrella Immunopharma to cross-verify your projections. Estrella Immunopharma Additional Predictive Modules
Most predictive techniques to examine Estrella price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Estrella using various technical indicators. When you analyze Estrella charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Estrella Immunopharma Simple Moving Average Price Forecast For the 2nd of February
Given 90 days horizon, the Simple Moving Average forecasted value of Estrella Immunopharma on the next trading day is expected to be 1.12 with a mean absolute deviation of 0.13, mean absolute percentage error of 0.03, and the sum of the absolute errors of 7.77.Please note that although there have been many attempts to predict Estrella Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Estrella Immunopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Estrella Immunopharma Stock Forecast Pattern
| Backtest Estrella Immunopharma | Estrella Immunopharma Price Prediction | Buy or Sell Advice |
Estrella Immunopharma Forecasted Value
In the context of forecasting Estrella Immunopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Estrella Immunopharma's downside and upside margins for the forecasting period are 0.01 and 9.48, respectively. We have considered Estrella Immunopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Estrella Immunopharma stock data series using in forecasting. Note that when a statistical model is used to represent Estrella Immunopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.9004 |
| Bias | Arithmetic mean of the errors | 0.0343 |
| MAD | Mean absolute deviation | 0.1316 |
| MAPE | Mean absolute percentage error | 0.0789 |
| SAE | Sum of the absolute errors | 7.765 |
Predictive Modules for Estrella Immunopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Estrella Immunopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Estrella Immunopharma After-Hype Price Density Analysis
As far as predicting the price of Estrella Immunopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Estrella Immunopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Estrella Immunopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Estrella Immunopharma Estimiated After-Hype Price Volatility
In the context of predicting Estrella Immunopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Estrella Immunopharma's historical news coverage. Estrella Immunopharma's after-hype downside and upside margins for the prediction period are 0.06 and 9.49, respectively. We have considered Estrella Immunopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Estrella Immunopharma is abnormally volatile at this time. Analysis and calculation of next after-hype price of Estrella Immunopharma is based on 3 months time horizon.
Estrella Immunopharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Estrella Immunopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Estrella Immunopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Estrella Immunopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.24 | 8.36 | 0.07 | 0.18 | 5 Events / Month | 6 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.12 | 1.12 | 0.00 |
|
Estrella Immunopharma Hype Timeline
Estrella Immunopharma is currently traded for 1.12. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of 0.18. Estrella is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -1.24%. %. The volatility of related hype on Estrella Immunopharma is about 5805.56%, with the expected price after the next announcement by competition of 1.30. About 70.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.24. Estrella Immunopharma had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 5 days. Check out Historical Fundamental Analysis of Estrella Immunopharma to cross-verify your projections.Estrella Immunopharma Related Hype Analysis
Having access to credible news sources related to Estrella Immunopharma's direct competition is more important than ever and may enhance your ability to predict Estrella Immunopharma's future price movements. Getting to know how Estrella Immunopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Estrella Immunopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EXOZ | eXoZymes | (0.71) | 6 per month | 0.00 | (0.04) | 11.43 | (6.95) | 26.73 | |
| GLSI | Greenwich Lifesciences | 0.02 | 23 per month | 5.33 | 0.25 | 19.77 | (10.29) | 36.51 | |
| ATOS | Atossa Genetics | 0.01 | 11 per month | 0.00 | (0.17) | 6.78 | (6.67) | 20.34 | |
| SRZN | Surrozen | 2.17 | 10 per month | 4.28 | 0.13 | 13.34 | (6.75) | 34.29 | |
| ANEB | Anebulo Pharmaceuticals | (0.07) | 10 per month | 0.00 | (0.19) | 5.06 | (11.61) | 36.64 | |
| TVGN | Tevogen Bio Holdings | 0.01 | 9 per month | 0.00 | (0.17) | 10.00 | (8.89) | 26.81 | |
| ONCY | Oncolytics Biotech | (0.01) | 12 per month | 0.00 | (0.04) | 8.55 | (8.40) | 27.19 | |
| TIL | Instil Bio | (0.24) | 9 per month | 0.00 | (0.18) | 6.59 | (9.97) | 55.58 | |
| TLSA | Tiziana Life Sciences | 0.00 | 0 per month | 0.00 | (0.06) | 7.41 | (5.81) | 21.81 | |
| IMMX | Immix Biopharma | 0.26 | 7 per month | 4.20 | 0.15 | 15.04 | (8.41) | 28.79 |
Other Forecasting Options for Estrella Immunopharma
For every potential investor in Estrella, whether a beginner or expert, Estrella Immunopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Estrella Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Estrella. Basic forecasting techniques help filter out the noise by identifying Estrella Immunopharma's price trends.Estrella Immunopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Estrella Immunopharma stock to make a market-neutral strategy. Peer analysis of Estrella Immunopharma could also be used in its relative valuation, which is a method of valuing Estrella Immunopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Estrella Immunopharma Market Strength Events
Market strength indicators help investors to evaluate how Estrella Immunopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Estrella Immunopharma shares will generate the highest return on investment. By undertsting and applying Estrella Immunopharma stock market strength indicators, traders can identify Estrella Immunopharma entry and exit signals to maximize returns.
Estrella Immunopharma Risk Indicators
The analysis of Estrella Immunopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Estrella Immunopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting estrella stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.87 | |||
| Standard Deviation | 8.87 | |||
| Variance | 78.73 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Estrella Immunopharma
The number of cover stories for Estrella Immunopharma depends on current market conditions and Estrella Immunopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Estrella Immunopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Estrella Immunopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Estrella Immunopharma Short Properties
Estrella Immunopharma's future price predictability will typically decrease when Estrella Immunopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Estrella Immunopharma often depends not only on the future outlook of the potential Estrella Immunopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Estrella Immunopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.7 M | |
| Cash And Short Term Investments | 916.9 K |
Check out Historical Fundamental Analysis of Estrella Immunopharma to cross-verify your projections. For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Estrella Immunopharma. Projected growth potential of Estrella fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Estrella Immunopharma assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Estrella Immunopharma is measured differently than its book value, which is the value of Estrella that is recorded on the company's balance sheet. Investors also form their own opinion of Estrella Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Estrella Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Estrella Immunopharma's market value can be influenced by many factors that don't directly affect Estrella Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Estrella Immunopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Estrella Immunopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Estrella Immunopharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.